298 related articles for article (PubMed ID: 30246311)
1. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
3. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
Wang W; Wang S; Chu X; Liu H; Xiang M
J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
[TBL] [Abstract][Full Text] [Related]
4. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
Huang G; Zhang J; Gong L; Huang Y; Liu D
BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
[TBL] [Abstract][Full Text] [Related]
5. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
[TBL] [Abstract][Full Text] [Related]
6. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
7. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
8. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
Xu F; Zhang H; Chen J; Lin L; Chen Y
Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel CpG methylation signature to predict prognosis in lung squamous cell carcinoma.
Lee N; Xia X; Meng H; Zhu W; Wang X; Zhang T; Zhang C; Zhang J; Luo P
Cancer Biomark; 2021; 30(1):63-73. PubMed ID: 32924987
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
[TBL] [Abstract][Full Text] [Related]
11. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Wang X; Wang X; Li X; Chang Y
J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
[No Abstract] [Full Text] [Related]
13. A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma.
Wang W; Xiang M; Liu H; Chu X; Sun Z; Feng L
PeerJ; 2022; 10():e13057. PubMed ID: 35356464
[TBL] [Abstract][Full Text] [Related]
14. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
15. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
17. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
Yang K; Wu Y
BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Gao M; Kong W; Huang Z; Xie Z
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340320
[TBL] [Abstract][Full Text] [Related]
19. A novel immunogenomic prognostic signature in lung squamous carcinoma.
Hou J; Zhong Q
Medicine (Baltimore); 2021 Jan; 100(2):e24073. PubMed ID: 33466167
[TBL] [Abstract][Full Text] [Related]
20. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]